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EDITORIAL

Interventional Nephrology: Recrudescent
and Ascendant

I

t is 2009 and with it comes the stretch goal of
achieving a nationwide fistula prevalence
rate of 66%. Are we there yet? No, but the
impetus of the national arteriovenous (AV)
‘‘Fistula First’’ initiative has resulted in better
planning of vascular access constructions and
clearly more of them, with a 52.3% point prevalence as of April 2009 (http://www.esrdncc.
org/index/cms-filesystem-action?file¼/fistul
afirstdashboard2.pdf). Launched in early 2003,
this project was designed by the Centers for
Medicare and Medicaid Services, the 18
ESRD Networks, and the Institute for Healthcare Improvement as a 3-year initiative whose
goal was to specifically increase the use of AV
fistulae for hemodialysis access.
Thereafter, Fistula First generated intense
activity among nephrology groups. Dedicated
education in pre-ESRD classes was developed
to more fully inform patients regarding the
various modalities of renal replacement therapy and their knowledge of vascular accesses
and peritoneal dialysis catheters. CKD clinical
activity rose, despite the busy schedules of
nephrologists, and patient visits were increasingly punctuated by discussions for the necessity to ‘‘see the vascular access surgeon.’’
Academic curricula for fellows-in-training
now included dedicated and specific learning
objectives regarding vascular access. More
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frequent and dedicated collaborations took
place among nephrologists, CKD and ESRD
nursing staffs, interventional radiologists,
and vascular access surgeons. Nowhere did
such dedication to the vascular access and
collaboration among interested parties occur
than at the Aberdeen Dialysis Center, in
Olympia, WA, where the AV fistula prevalence rate grew to 90%. To achieve this
outcome, an epiphany had to occur first:
vascular access care was important, equally
important as the other domains of ESRD care.
However, the success of this center did not
become viral, at least not yet, and, despite Fistula First’s laudable agenda and its aggressive
promulgation, the rate of hemodialysis catheter implantations substantially increased,
clearly an unintended consequence. How did
this happen? A fundamental aspect of Fistula
First was ignored, which is ‘‘to increase AVF
use for all suitable hemodialysis patients.’’
Blind devotion to the goal, without appropriate intermediary evaluations, resulted in
failed fistulas and subsequent hemodialysis
catheter insertions in patients who were not
a priori suitable for a fistula. Failure to heed
the past dooms one to repeat history, and,
thus, each dialysis medical center director
should have a specific vascular access plan
that is wedded to best practice, performance
metrics, and clinical outcomes, and this is
not a trivial document.
Catheter insertions are neither benign nor
inexpensive. Catheter insertions may subvert
future opportunities for the creation of AV
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fistulas and/or grafts by inducing venous stenosis that may not be amenable to repair. This
complex pathobiological response is exposited
in this issue of Advances of Chronic Kidney Disease. The expenses associated with catheterrelated blood stream infections have staggered
the healthcare payment system. Therefore,
a moderation of Fistula First may be called
for: the most suitable arteriovenous access
for each ESRD patient that opts for hemodialysis. Nonetheless, the nephrologist is responsible for the care of his/her patients, and it is
incumbent that we acknowledge the burgeoning vascular access body of knowledge.
Failure to do so fails our patients.
Some nephrology groups, particularly
those that are particularly large, have literally
‘‘taken matters into their own hands.’’ They
construct their own fistulas, a practice that
had already taken foothold in Europe, and
this stem-to-stern approach is described
herein. In general, vascular access construction will not be in the toolkit of the majority
of practicing nephrology groups in the United
States; however, the emergence of interventional nephrology as a bona fide clinical
domain of CKD care challenges the concept
of what constitutes a nephrologist. The development of expertise in interventional techniques involves cognitive skills combined
with multiple procedural competencies. These
competencies must now be shown in a volume-based fashion, with sufficient quality, as
delineated by the multidisciplinary American
Society of Diagnostic and Interventional
Nephrology.
Accordingly, as with many other subspecialties of internal medicine, the nephrologist
as a proceduralist has become a reality. In
truth, the nephrologist was already, and the
history of interventional nephrology divulged
in this compendium attests to this fact.

Belding Scribner and his collaborator, biomedical expert Wayne Quinton, and, later, chemical engineering professor Les Babb, devised
the first AV fistula in 1960 in order that hemodialysis could be accomplished in an extended
format, not simply until the patient’s arteries
and veins were depleted by repeated cannulations.
During those formative years of vascular
access, the nephrologist drove technological
and surgical advances so much so that these
advances outstripped those of the hulking
dialysis machine itself. Over several decades,
nephrologists’ interest in vascular access
waned, and access care was forfeited to vascular surgeons, rarely vascular access surgeons.
The ability for the nephrologist to cannulate
an access, once a clinical requirement, became
an anachronism. AV grafts and ‘‘permanent’’
tunneled, cuffed catheter insertions became
norms rather than exceptions, that is, until
the catheter-induced complications began to
appear persistently on the quality dashboards
of many hospitals and piqued the interests of
so-called ‘‘quality’’ fora and institutions.
So, interventional nephrology is not new; it
is recrudescent after a period of prolonged
dormancy. The affirmation of board-certifying
bodies that fellows-in-training must develop
not only a knowledge base regarding peritoneal and vascular accesses but also a defined
level of procedural competence will accelerate
the re-emergence of this welcome subdiscipline of kidney care. As the sciences of vascular biology and vascular access, with its
attendant techniques, converge and continue
to grow, interventional nephrology will
become ascendant once more and so will
patient outcomes.
Jerry Yee, MD
Editor

